Global Insulin Infusion Pumps Market, By Product (Insulin Pumps, Infusion Sets, Reservoirs), Application (Type I Diabetes, Type II Diabetes), End User (Hospitals and Clinics, Home Care, Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Insulin Infusion Pumps Market
Insulin infusion pumps market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 12,484.50 million by 2028 growing at a CAGR of 10.20% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of insulin infusion pumps which will create lucrative opportunities for the growth of the market.
Insulin infusion pumps are a replacement for a traditional regular injection device or an insulin pen. Compared to injections, the Insulin Infusion pumps ease the large changes in blood glucose level, have less discomfort, administer more reliably. It does not require meal timing to be prepared and therefore makes it more user-friendly for patients to turn to the use of infusion pumps. Insulin therapy is also called the injection of subcutaneous insulin. A variety of technical developments have been experienced by the subcutaneous insulin infusion technology, such as integrating continuous glucose monitoring with the pump. Now, after analysing the blood glucose reading, the insulin pump can control the algorithm which spontaneously delivers the insulin.
Surging volume of patients suffering from type 1 and type 2 diabetes, rising awareness among the people towards diabetes and insulin delivery devices, increasing development of the artificial pancreas and home infusion therapy, increasing prevalence of geriatric population across the globe, rising demand for personalised medicines, surging levels of investment by the government in the healthcare centers are some of the major as well as vital factors which will likely to augment the growth of the insulin infusion pumps market in the projected timeframe of 2021-2028. On the other hand, emergence of artificial intelligence in diabetes care devices along with professional as well as consumer information programs provided by the insulin infusion pump manufacturer which will further contribute by generating massive opportunities that will lead to the growth of the insulin infusion pumps market in the above mentioned projected timeframe.
High cost associated with the usages of devices along with product recalls and strict regulations for new products which will likely to act as market restraints factor for the growth of the insulin infusion pumps in the above mentioned projected timeframe. Strict FDA policies for the approval of the product which will become the biggest and foremost challenge for the growth of the market.
This insulin infusion pumps market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on insulin infusion pumps market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Insulin Infusion Pumps Market Scope and Market Size
Insulin infusion pumps market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product, the insulin infusion pumps market is segmented into insulin pumps, infusion sets, and reservoirs.
- Insulin infusion pumps market has also been segmented based on the end user into hospitals and clinics, home care, and laboratories.
- Based on application, the insulin infusion pumps market is segmented into type I diabetes, and type II diabetes.
Insulin Infusion Pumps Market Country Level Analysis
Insulin infusion pumps market is analysed and market size insights and trends are provided by country, product, application and end user as referenced above.
The countries covered in the insulin infusion pumps market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the insulin infusion pumps market due to the prevalence of favourable reimbursement policies in the region, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the increasing healthcare expenditure and rapidly developing healthcare sector.
The country section of the insulin infusion pumps market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Insulin infusion pumps market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for insulin infusion pumps market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the insulin infusion pumps market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Insulin Infusion Pumps Market Share Analysis
Insulin infusion pumps market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to insulin infusion pumps market.
The major players covered in the insulin infusion pumps market report are BIGFOOT BIOMEDICAL, INC.; Insulet Corporation.; Medtronic; F. Hoffmann-La Roche Ltd; Smiths Group PLC; SOOIL Developments Co., Ltd; Tandem Diabetes Care, Inc.; NIPRO; Zhengzhou Phray Technology Co., Ltd.; Shinmyung Mediyes CO., LTD.; MicroPort Scientific Corporation.; Ypsomed; BD; Abbott.; B. Braun Melsungen AG; Sanofi; Jiangsu Delfu medical device Co.,Ltd; Fresenius SE & Co. KGaA; ICU Medical, Inc.; Moog Inc.; among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-